KATHY THOMAS: Open Payments
NPI 1396159026 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 12 payments from 6 companies in 2025. Trend: 2023 $433 · 2024 $376 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $79 |
| Novo Nordisk Inc | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Fabhalta, Kerendia, Vanrafia, Ozempic, SHINGRIX, INJECTAFER, JARDIANCE.
Industry payments across MS — which companies pay providers there.
